Alfuzosin
Composition
The formulation contains Alfuzosin PR/MR as the active ingredient.
Indications
Benign prostatic hyperplasia, urinary retention
Side effects
Dizziness, headache and orthostatic hypotension.
Precautions
Use caution in patients with hepatic impairment or history of syncope.
Contraindications
Hypersensitivity, severe hepatic impairment, concurrent use of potent CYP3A4 inhibitors.
Dosage and administration
As directed by healthcare provider
Countries
USA, UK, Germany
Available Forms
Tablets
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai